Stock Scorecard
Stock Summary for Amedisys Inc (AMED) - $91.58 as of 5/8/2025 7:27:17 PM EST
Total Score
13 out of 30
Safety Score
46 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for AMED
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AMED
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AMED
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AMED
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for AMED (46 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 5 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AMED
Financial Details for AMED
Company Overview |
|
|---|---|
| Ticker | AMED |
| Company Name | Amedisys Inc |
| Country | USA |
| Description | Amedisys, Inc., provides healthcare services in the United States. The company is headquartered in Baton Rouge, Louisiana. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SERVICES-HOME HEALTH CARE SERVICES |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 91.58 |
| Price 4 Years Ago | 161.88 |
| Last Day Price Updated | 5/8/2025 7:27:17 PM EST |
| Last Day Volume | 545,576 |
| Average Daily Volume | 384,354 |
| 52-Week High | 98.95 |
| 52-Week Low | 82.15 |
| Last Price to 52 Week Low | 11.48% |
Valuation Measures |
|
| Trailing PE | 35.13 |
| Industry PE | 25.74 |
| Sector PE | 45.26 |
| 5-Year Average PE | 32.25 |
| Free Cash Flow Ratio | 10.55 |
| Industry Free Cash Flow Ratio | 26.67 |
| Sector Free Cash Flow Ratio | 29.93 |
| Current Ratio Most Recent Quarter | 1.29 |
| Total Cash Per Share | 8.68 |
| Book Value Per Share Most Recent Quarter | 36.55 |
| Price to Book Ratio | 2.63 |
| Industry Price to Book Ratio | 3.30 |
| Sector Price to Book Ratio | 21.41 |
| Price to Sales Ratio Twelve Trailing Months | 1.33 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.56 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.24 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 32,819,600 |
| Market Capitalization | 3,005,618,968 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.63% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 318.20% |
| Annual Earnings Growth | 543.53% |
| Reported EPS 12 Trailing Months | 2.71 |
| Reported EPS Past Year | 1.25 |
| Reported EPS Prior Year | 4.31 |
| Net Income Twelve Trailing Months | 114,392,000 |
| Net Income Past Year | 43,231,000 |
| Net Income Prior Year | -9,747,000 |
| Quarterly Revenue Growth YOY | 4.10% |
| 5-Year Revenue Growth | 3.73% |
| Operating Margin Twelve Trailing Months | 10.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 284,881,000 |
| Total Cash Past Year | 303,242,000 |
| Total Cash Prior Year | 126,450,000 |
| Net Cash Position Most Recent Quarter | -48,066,000 |
| Net Cash Position Past Year | -36,071,000 |
| Long Term Debt Past Year | 339,313,000 |
| Long Term Debt Prior Year | 361,862,000 |
| Total Debt Most Recent Quarter | 332,947,000 |
| Equity to Debt Ratio Past Year | 0.77 |
| Equity to Debt Ratio Most Recent Quarter | 0.78 |
| Total Stockholder Equity Past Year | 1,134,541,000 |
| Total Stockholder Equity Prior Year | 1,066,513,999 |
| Total Stockholder Equity Most Recent Quarter | 1,199,626,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 219,238,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 6.68 |
| Free Cash Flow Past Year | 215,115,000 |
| Free Cash Flow Prior Year | 124,475,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.05 |
| MACD Signal | 0.75 |
| 20-Day Bollinger Lower Band | 89.62 |
| 20-Day Bollinger Middle Band | 92.41 |
| 20-Day Bollinger Upper Band | 95.20 |
| Beta | 0.89 |
| RSI | 73.24 |
| 50-Day SMA | 93.64 |
| 150-Day SMA | 94.01 |
| 200-Day SMA | 110.73 |
System |
|
| Modified | 5/8/2025 5:15:35 PM EST |